Stock listing
Lipigon Pharmaceuticals Ab
Selected listing: LPGO · OMXSTO · SEK · SE
Lipigon Pharmaceuticals Ab (Stockholm:LPGO), Health Technology. Latest release Dec 22, 2025: PLX: Secarna’s Antisense Oligonucleotide Discovery Collaboration.
- Ticker
- Stockholm:LPGO
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Stockholm
- Currency
- SEK
About Lipigon Pharmaceuticals Ab
Lipigon Pharmaceuticals Ab (ticker: LPGO) is a public company based in Sweden, focused on developing innovative therapies for lipid-related diseases. The company is committed to advancing its research and development efforts to bring new treatments to market.
Latest news from Lipigon Pharmaceuticals Ab
Research Lipigon Pharmaceuticals Ab
Lipigon Pharmaceuticals Ab company profile
View the public company page for Lipigon Pharmaceuticals Ab on 6ix.
Lipigon Pharmaceuticals Ab news
Read company news and market updates connected to Lipigon Pharmaceuticals Ab.
Lipigon Pharmaceuticals Ab investor events
Find investor webinars, events, and replay context for Lipigon Pharmaceuticals Ab.
Alternate listings
A2QP0Q:LSX
DE · EUR
Alternate listing for Lipigon Pharmaceuticals Ab; the primary context on this page is LPGO:OMXSTO.
9RP:FWB
DE · EUR
Alternate listing for Lipigon Pharmaceuticals Ab; the primary context on this page is LPGO:OMXSTO.
9RP:GETTEX
DE · EUR
Alternate listing for Lipigon Pharmaceuticals Ab; the primary context on this page is LPGO:OMXSTO.
A2QP0Q:LS
DE · EUR
Alternate listing for Lipigon Pharmaceuticals Ab; the primary context on this page is LPGO:OMXSTO.
9RP:MUN
DE · EUR
Alternate listing for Lipigon Pharmaceuticals Ab; the primary context on this page is LPGO:OMXSTO.
9RP:SWB
DE · EUR
Alternate listing for Lipigon Pharmaceuticals Ab; the primary context on this page is LPGO:OMXSTO.